References:
1. Chugh SS, Havmoeller R, Narayanan K et al. Worldwide epidemiology of
atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation
2014;129:837-47.
2. Blum S, Meyre P, Aeschbacher S et al. Incidence and predictors of
atrial fibrillation progression: A systematic review and meta-analysis.
Heart Rhythm 2019;16:502-510.
3. Conen D, Chae CU, Glynn RJ et al. Risk of death and cardiovascular
events in initially healthy women with new-onset atrial fibrillation.
JAMA 2011;305:2080-2087.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent
risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
5. Kirchhof P, Camm AJ, Goette A et al. Early Rhythm-Control Therapy in
Patients with Atrial Fibrillation. New England Journal of Medicine
2020;383:1305-1316.
6. Haïssaguerre M, Jaïs P, Shah DC et al. Spontaneous initiation of
atrial fibrillation by ectopic beats originating in the pulmonary veins.
N Engl J Med 1998;339:659-66.
7. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural
abnormalities in atrial walls are associated with presence and
persistency of atrial fibrillation but not with age. J Am Coll Cardiol
2011;58:2225-32.
8. Lau DH, Linz D, Schotten U, Mahajan R, Sanders P, Kalman JM.
Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation:
Rotors, Foci and Fibrosis. Heart Lung Circ 2017;26:887-893.
9. Calkins H, Hindricks G, Cappato R et al. 2017
HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and
surgical ablation of atrial fibrillation. Heart Rhythm
2017;14:e275-e444.
10. Kanagaratnam L, Tomassoni G, Schweikert R et al. Empirical pulmonary
vein isolation in patients with chronic atrial fibrillation using a
three-dimensional nonfluoroscopic mapping system: long-term follow-up.
Pacing and clinical electrophysiology : PACE 2001;24:1774-9.
11. Pappone C, Rosanio S, Oreto G et al. Circumferential radiofrequency
ablation of pulmonary vein ostia: A new anatomic approach for curing
atrial fibrillation. Circulation 2000;102:2619-28.
12. Tada H, Oral H, Wasmer K et al. Pulmonary vein isolation: comparison
of bipolar and unipolar electrograms at successful and unsuccessful
ostial ablation sites. Journal of cardiovascular electrophysiology
2002;13:13-9.
13. Proietti R, Santangeli P, Di Biase L et al. Comparative
effectiveness of wide antral versus ostial pulmonary vein isolation: a
systematic review and meta-analysis. Circ Arrhythm Electrophysiol
2014;7:39-45.
14. Medi C, Sparks PB, Morton JB et al. Pulmonary vein antral isolation
for paroxysmal atrial fibrillation: results from long-term follow-up. J
Cardiovasc Electrophysiol 2011;22:137-41.
15. Nilsson B, Chen X, Pehrson S, Køber L, Hilden J, Svendsen JH.
Recurrence of pulmonary vein conduction and atrial fibrillation after
pulmonary vein isolation for atrial fibrillation: a randomized trial of
the ostial versus the extraostial ablation strategy. Am Heart J
2006;152:537.e1-8.
16. Mohanty S, Mohanty P, Di Biase L et al. Long-term follow-up of
patients with paroxysmal atrial fibrillation and severe left atrial
scarring: comparison between pulmonary vein antrum isolation only or
pulmonary vein isolation combined with either scar homogenization or
trigger ablation. Europace 2017;19:1790-1797.
17. Zhao Y, Di Biase L, Trivedi C et al. Importance of
non–pulmonary vein triggers ablation to achieve long-term
freedom from paroxysmal atrial fibrillation in patients with low
ejection fraction. Heart Rhythm 2016;13:141-149.
18. Santangeli P, Zado ES, Hutchinson MD et al. Prevalence and
distribution of focal triggers in persistent and long-standing
persistent atrial fibrillation. Heart Rhythm 2016;13:374-82.
19. Gökoğlan Y, Mohanty S, Güneş MF et al. Pulmonary Vein Antrum
Isolation in Patients With Paroxysmal Atrial Fibrillation: More Than a
Decade of Follow-Up. Circ Arrhythm Electrophysiol 2016;9.
20. Mohanty S, Trivedi C, Horton P et al. Natural History of Arrhythmia
After Successful Isolation of Pulmonary Veins, Left Atrial Posterior
Wall, and Superior Vena Cava in Patients With Paroxysmal Atrial
Fibrillation: A Multi-Center Experience. J Am Heart Assoc
2021;10:e020563.
21. Nademanee K, McKenzie J, Kosar E et al. A new approach for catheter
ablation of atrial fibrillation: mapping of the electrophysiologic
substrate. J Am Coll Cardiol 2004;43:2044-53.
22. Verma A, Mantovan R, Macle L et al. Substrate and Trigger Ablation
for Reduction of Atrial Fibrillation (STAR AF): a randomized,
multicentre, international trial. Eur Heart J 2010;31:1344-56.
23. Hayward RM, Upadhyay GA, Mela T et al. Pulmonary vein isolation with
complex fractionated atrial electrogram ablation for paroxysmal and
nonparoxysmal atrial fibrillation: A meta-analysis. Heart Rhythm
2011;8:994-1000.
24. Dixit S, Marchlinski FE, Lin D et al. Randomized Ablation Strategies
for the Treatment of Persistent Atrial Fibrillation. Circulation:
Arrhythmia and Electrophysiology 2012;5:287-294.
25. Verma A, Jiang C-y, Betts TR et al. Approaches to Catheter Ablation
for Persistent Atrial Fibrillation. New England Journal of Medicine
2015;372:1812-1822.
26. Sau A, Al-Aidarous S, Howard J et al. Optimum lesion set and
predictors of outcome in persistent atrial fibrillation ablation: a
meta-regression analysis. Europace : European pacing, arrhythmias, and
cardiac electrophysiology : journal of the working groups on cardiac
pacing, arrhythmias, and cardiac cellular electrophysiology of the
European Society of Cardiology 2019;21:1176-1184.
27. Chen YH, Lin H, Wang Q, Hou JW, Li YG. Efficacy and Safety of
Adjunctive Substrate Modification During Pulmonary Vein Isolation for
Atrial Fibrillation: A Meta-Analysis. Heart, lung & circulation
2020;29:422-436.
28. Nakai K, Kashiwa A, Kunitomi A, Matsuoka S. Conduction gap mapping
of linear ablation lesions with high density mapping. Journal of
cardiovascular electrophysiology 2020.
29. Yao Y, Hu F, Du Z et al. The value of extensive catheter linear
ablation on persistent atrial fibrillation (the CLEAR-AF Study). Int J
Cardiol 2020;316:125-129.
30. Inoue K, Hikoso S, Masuda M et al. Pulmonary vein isolation alone
vs. more extensive ablation with defragmentation and linear ablation of
persistent atrial fibrillation: the EARNEST-PVI trial. Europace
2021;23:565-574.
31. Gillis K, O’Neill L, Wielandts J-Y et al. Vein of Marshall Ethanol
Infusion as First Step for Mitral Isthmus Linear Ablation. JACC:
Clinical Electrophysiology 2022;8:367-376.
32. Nakashima T, Pambrun T, Vlachos K et al. Strategy for repeat
procedures in patients with persistent atrial fibrillation: Systematic
linear ablation with adjunctive ethanol infusion into the vein of
Marshall versus electrophysiology-guided ablation. J Cardiovasc
Electrophysiol 2022.
33. Lai Y, Liu X, Sang C et al. Effectiveness of ethanol infusion into
the vein of Marshall combined with a fixed anatomical ablation strategy
(the ”upgraded 2C3L” approach) for catheter ablation of persistent
atrial fibrillation. J Cardiovasc Electrophysiol 2021;32:1849-1856.
34. Pontoppidan J, Nielsen JC, Poulsen SH et al. Prophylactic
cavotricuspid isthmus block during atrial fibrillation ablation in
patients without atrial flutter: a randomised controlled trial. Heart
2009;95:994-9.
35. Mesquita J, Ferreira AM, Cavaco D et al. Impact of prophylactic
cavotricuspid isthmus ablation in atrial fibrillation recurrence after a
first pulmonary vein isolation procedure. Int J Cardiol 2018;259:82-87.
36. Kim SH, Oh YS, Choi Y et al. Long-Term Efficacy of Prophylactic
Cavotricuspid Isthmus Ablation during Atrial Fibrillation Ablation in
Patients Without Typical Atrial Flutter: a Prospective, Multicentre,
Randomized Trial. Korean Circ J 2021;51:58-64.
37. Romero J, Patel K, Briceno D et al. Cavotricuspid isthmus line in
patients undergoing catheter ablation of atrial fibrillation with or
without history of typical atrial flutter: A meta-analysis. J Cardiovasc
Electrophysiol 2020;31:1987-1995.
38. Gucuk Ipek E, Marine J, Yang E et al. Predictors and Incidence of
Atrial Flutter After Catheter Ablation of Atrial Fibrillation. The
American journal of cardiology 2019;124:1690-1696.
39. Krummen DE, Swarup V, Narayan SM. The role of rotors in atrial
fibrillation. J Thorac Dis 2015;7:142-151.
40. Davidenko JM, Kent PF, Chialvo DR, Michaels DC, Jalife J. Sustained
vortex-like waves in normal isolated ventricular muscle. Proceedings of
the National Academy of Sciences of the United States of America
1990;87:8785-9.
41. Narayan SM, Shivkumar K, Krummen DE, Miller JM, Rappel WJ. Panoramic
electrophysiological mapping but not electrogram morphology identifies
stable sources for human atrial fibrillation: stable atrial fibrillation
rotors and focal sources relate poorly to fractionated electrograms.
Circulation Arrhythmia and electrophysiology 2013;6:58-67.
42. Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller
JM. Treatment of atrial fibrillation by the ablation of localized
sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or
Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol
2012;60:628-36.
43. Peigh G, Wasserlauf J, Kaplan RM et al. Repeat pulmonary vein
isolation with or without FIRM-guided ablation for recurrent atrial
fibrillation with pulmonary vein reconnection. Journal of cardiovascular
electrophysiology 2020;31:1031-1037.
44. Tilz R, Lenz CL, Sommer PS et al. P2846Focal impulse and rotor
modulation ablation versus pulmonary vein isolation for the treatment of
paroxysmal atrial fibrillation (FIRMAP AF study). European Heart Journal
2019;40.
45. Mohanty S, Mohanty P, Trivedi C et al. Long-Term Outcome of
Pulmonary Vein Isolation With and Without Focal Impulse and Rotor
Modulation Mapping. Circulation: Arrhythmia and Electrophysiology
2018;11:e005789.
46. Liu PR, Friedman DJ, Barnett AS, Jackson KP, Daubert JP, Piccini JP.
Focal impulse and rotor modulation of atrial rotors during atrial
fibrillation leads to organization of left atrial activation as
reflected by waveform morphology recurrence quantification analysis and
organizational index. Journal of arrhythmia 2020;36:311-318.
47. Romero J, Gabr M, Alviz I et al. Focal impulse and rotor modulation
guided ablation versus pulmonary vein isolation for atrial fibrillation:
A meta-analysis of head-to-head comparative studies. Journal of
Cardiovascular Electrophysiology 2021;32:1822-1832.
48. Blandino A, Bianchi F, Grossi S et al. Left Atrial Substrate
Modification Targeting Low-Voltage Areas for Catheter Ablation of Atrial
Fibrillation: A Systematic Review and Meta-Analysis. Pacing Clin
Electrophysiol 2017;40:199-212.
49. Bisbal F, Benito E, Teis A et al. Magnetic Resonance Imaging-Guided
Fibrosis Ablation for the Treatment of Atrial Fibrillation: The ALICIA
Trial. Circulation: Arrhythmia and Electrophysiology;0.
50. Dean NFMTGJM. Efficacy of LGE-MRI-guided fibrosis ablation versus
conventional catheter ablation of atrial fibrillation:The DECAAF II
trial. in press 2021.
51. Yamaguchi T, Tsuchiya T, Nakahara S et al. Efficacy of Left Atrial
Voltage-Based Catheter Ablation of Persistent Atrial Fibrillation. J
Cardiovasc Electrophysiol 2016;27:1055-63.
52. Kottkamp H, Berg J, Bender R, Rieger A, Schreiber D. Box Isolation
of Fibrotic Areas (BIFA): A Patient-Tailored Substrate Modification
Approach for Ablation of Atrial Fibrillation. J Cardiovasc
Electrophysiol 2016;27:22-30.
53. Abdulla R, Blew GA, Holterman MJ. Cardiovascular embryology. Pediatr
Cardiol 2004;25:191-200.
54. Suenari K, Chen YC, Kao YH et al. Discrepant electrophysiological
characteristics and calcium homeostasis of left atrial anterior and
posterior myocytes. Basic Res Cardiol 2011;106:65-74.
55. Hunter RJ, Liu Y, Lu Y, Wang W, Schilling RJ. Left Atrial Wall
Stress Distribution and Its Relationship to Electrophysiologic
Remodeling in Persistent Atrial Fibrillation. Circulation: Arrhythmia
and Electrophysiology 2012;5:351-360.
56. Katritsis DG, Pokushalov E, Romanov A et al. Autonomic denervation
added to pulmonary vein isolation for paroxysmal atrial fibrillation: a
randomized clinical trial. J Am Coll Cardiol 2013;62:2318-25.
57. Driessen AHG, Berger WR, Krul SPJ et al. Ganglion Plexus Ablation in
Advanced Atrial Fibrillation: The AFACT Study. J Am Coll Cardiol
2016;68:1155-1165.
58. Kampaktsis PN, Oikonomou EK, D YC, Cheung JW. Efficacy of
ganglionated plexi ablation in addition to pulmonary vein isolation for
paroxysmal versus persistent atrial fibrillation: a meta-analysis of
randomized controlled clinical trials. J Interv Card Electrophysiol
2017;50:253-260.
59. Lim HS, Hocini M, Dubois R et al. Complexity and Distribution of
Drivers in Relation to Duration of Persistent Atrial Fibrillation.
Journal of the American College of Cardiology 2017;69:1257-1269.
60. Bai R, Di Biase L, Mohanty P et al. Proven isolation of the
pulmonary vein antrum with or without left atrial posterior wall
isolation in patients with persistent atrial fibrillation. Heart Rhythm
2016;13:132-40.
61. DeLurgio DB, Crossen KJ, Gill J et al. Hybrid Convergent Procedure
for the Treatment of Persistent and Long-Standing Persistent Atrial
Fibrillation. Circulation: Arrhythmia and Electrophysiology
2020;13:e009288.
62. Ahn J, Shin DG, Han SJ, Lim HE. Does isolation of the left atrial
posterior wall using cryoballoon ablation improve clinical outcomes in
patients with persistent atrial fibrillation? A prospective randomized
controlled trial. Europace 2022.
63. Aryana A, Allen SL, Pujara DK et al. Concomitant Pulmonary Vein and
Posterior Wall Isolation Using Cryoballoon With Adjunct Radiofrequency
in Persistent Atrial Fibrillation. JACC Clin Electrophysiol
2021;7:187-196.
64. Mun H-S, Joung B, Shim J et al. Does additional linear ablation
after circumferential pulmonary vein isolation improve clinical outcome
in patients with paroxysmal atrial fibrillation? Prospective randomised
study. Heart (British Cardiac Society) 2012;98:480-484.
65. Tamborero D, Mont L, Berruezo A et al. Left atrial posterior wall
isolation does not improve the outcome of circumferential pulmonary vein
ablation for atrial fibrillation: a prospective randomized study. Circ
Arrhythm Electrophysiol 2009;2:35-40.
66. Lee JM, Shim J, Park J et al. The Electrical Isolation of the Left
Atrial Posterior Wall in Catheter Ablation of Persistent Atrial
Fibrillation. J Am Coll Cardiol EP 2019;5:1253-1261.
67. Pak H-N, Park J, Park J-W et al. Electrical Posterior Box Isolation
in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial
Fibrillation: A Multi-center, Prospective, Randomized Study (PEACEFUL).
Circulation: Arrhythmia and Electrophysiology;0.
68. Romero J, Polanco D, Alviz I et al. Posterior Wall Electrical
Isolation in Patients Undergoing Catheter Ablation for Paroxysmal and
Non-Paroxysmal Atrial Fibrillation:A Meta-Analysis of Randomized
Controlled Trial. Journal of American College of Cardiology EP 2021;in
press.
69. Hong KL, Baley J, Baranchuk A, Bisleri G, Glover BM. Epicardial
Electrical Activation During Atrial Fibrillation. Looking at the Other
Side of the Coin 2019;1:401-402.
70. Groot Nd, Does Lvd, Yaksh A et al. Direct Proof of Endo-Epicardial
Asynchrony of the Atrial Wall During Atrial Fibrillation in Humans.
Circulation: Arrhythmia and Electrophysiology 2016;9:e003648.
71. Markman TM, Hyman MC, Kumareswaran R et al. Durability of posterior
wall isolation after catheter ablation among patients with recurrent
atrial fibrillation. Heart rhythm : the official journal of the Heart
Rhythm Society 2020.
72. Schmidt M, Nölker G, Marschang H et al. Incidence of oesophageal
wall injury post-pulmonary vein antrum isolation for treatment of
patients with atrial fibrillation. Europace 2008;10:205-9.
73. Barbhaiya CR, Kumar S, John RM et al. Global survey of esophageal
and gastric injury in atrial fibrillation ablation: incidence, time to
presentation, and outcomes. J Am Coll Cardiol 2015;65:1377-1378.
74. Kiuchi K, Okajima K, Shimane A et al. Impact of esophageal
temperature monitoring guided atrial fibrillation ablation on preventing
asymptomatic excessive transmural injury. Journal of arrhythmia
2016;32:36-41.
75. Singh SM, d’Avila A, Doshi SK et al. Esophageal injury and
temperature monitoring during atrial fibrillation ablation. Circulation
Arrhythmia and electrophysiology 2008;1:162-8.
76. Zhang X, Kuang X, Gao X et al. RESCUE-AF in Patients Undergoing
Atrial Fibrillation Ablation. Circulation: Arrhythmia and
Electrophysiology 2019;12:e007044.
77. Verma A, Kilicaslan F, Adams JR et al. Extensive ablation during
pulmonary vein antrum isolation has no adverse impact on left atrial
function: an echocardiography and cine computed tomography analysis. J
Cardiovasc Electrophysiol 2006;17:741-6.
78. Kim JS, Shin SY, Na JO et al. Does isolation of the left atrial
posterior wall improve clinical outcomes after radiofrequency catheter
ablation for persistent atrial fibrillation?: A prospective randomized
clinical trial. Int J Cardiol 2015;181:277-83.
79. Tsai CF, Tai CT, Hsieh MH et al. Initiation of atrial fibrillation
by ectopic beats originating from the superior vena cava:
electrophysiological characteristics and results of radiofrequency
ablation. Circulation 2000;102:67-74.
80. Lin WS, Tai CT, Hsieh MH et al. Catheter ablation of paroxysmal
atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation
2003;107:3176-83.
81. Gianni C, Sanchez JE, Mohanty S et al. Isolation of the superior
vena cava from the right atrial posterior wall: a novel ablation
approach. Europace 2018;20:e124-e132.
82. Overeinder I, Osório TG, Călburean PA et al. Comparison between
superior vena cava ablation in addition to pulmonary vein isolation and
standard pulmonary vein isolation in patients with paroxysmal atrial
fibrillation with the cryoballoon technique. J Interv Card
Electrophysiol 2021;62:579-586.
83. Corrado A, Bonso A, Madalosso M et al. Impact of systematic
isolation of superior vena cava in addition to pulmonary vein antrum
isolation on the outcome of paroxysmal, persistent, and permanent atrial
fibrillation ablation: results from a randomized study. J Cardiovasc
Electrophysiol 2010;21:1-5.
84. Sharma SP, Sangha RS, Dahal K, Krishnamoorthy P. The role of empiric
superior vena cava isolation in atrial fibrillation: a systematic review
and meta-analysis of randomized controlled trials. J Interv Card
Electrophysiol 2017;48:61-67.
85. Yoshiga Y, Shimizu A, Ueyama T et al. Strict sequential catheter
ablation strategy targeting the pulmonary veins and superior vena cava
for persistent atrial fibrillation. J Cardiol 2018;72:128-134.
86. Della Rocca DG, Mohanty S, Mohanty P et al. Long-term outcomes of
catheter ablation in patients with longstanding persistent atrial
fibrillation lasting less than 2 years. J Cardiovasc Electrophysiol
2018;29:1607-1615.
87. Oral H, Ozaydin M, Chugh A et al. Role of the coronary sinus in
maintenance of atrial fibrillation. J Cardiovasc Electrophysiol
2003;14:1329-36.
88. Haïssaguerre M, Hocini M, Takahashi Y et al. Impact of catheter
ablation of the coronary sinus on paroxysmal or persistent atrial
fibrillation. J Cardiovasc Electrophysiol 2007;18:378-86.
89. Knecht S, O’Neill MD, Matsuo S et al. Focal arrhythmia confined
within the coronary sinus and maintaining atrial fibrillation. J
Cardiovasc Electrophysiol 2007;18:1140-6.
90. Chang HY, Lo LW, Lin YJ et al. Long-term outcome of catheter
ablation in patients with atrial fibrillation originating from
nonpulmonary vein ectopy. J Cardiovasc Electrophysiol 2013;24:250-8.
91. Morita H, Zipes DP, Morita ST, Wu J. Isolation of canine coronary
sinus musculature from the atria by radiofrequency catheter ablation
prevents induction of atrial fibrillation. Circ Arrhythm Electrophysiol
2014;7:1181-8.
92. Della Rocca DG, Di Biase L, Mohanty S et al. ELECTRICAL ISOLATION
VERSUS FOCAL ABLATION OF THE CORONARY SINUS IN PATIENTS WITH PERSISTENT
ATRIAL FIBRILLATION. Journal of the American College of Cardiology
2020;75:281.
93. Kuo L, Frankel DS, Lin A et al. PRECAF Randomized Controlled Trial.
Circ Arrhythm Electrophysiol 2021;14:e008993.
94. Güneş MF, Gökoğlan Y, L DIB et al. Ablating the Posterior Heart:
Cardioesophageal Fistula Complicating Radiofrequency Ablation in the
Coronary Sinus. J Cardiovasc Electrophysiol 2015;26:1376-8.
95. Di Biase L, Burkhardt JD, Mohanty P et al. Left atrial appendage: an
underrecognized trigger site of atrial fibrillation. Circulation
2010;122:109-18.
96. Di Biase L, Burkhardt JD, Mohanty P et al. Left Atrial Appendage
Isolation in Patients With Longstanding Persistent AF Undergoing
Catheter Ablation: BELIEF Trial. J Am Coll Cardiol 2016;68:1929-1940.
97. Romero J, Gabr M, Patel K et al. Efficacy and safety of left atrial
appendage electrical isolation during catheter ablation of atrial
fibrillation: an updated meta-analysis. EP Europace 2020;23:226-237.
98. Friedman DJ, Black-Maier EW, Barnett AS et al. Left Atrial Appendage
Electrical Isolation for Treatment of Recurrent Atrial Fibrillation: A
Meta-Analysis. J Am Coll Cardiol EP 2018;4:112-120.
99. Romero J, Di Biase L, Mohanty S et al. Long-Term Outcomes of Left
Atrial Appendage Electrical Isolation in Patients With Nonparoxysmal
Atrial Fibrillation: A Propensity Score-Matched Analysis. Circ Arrhythm
Electrophysiol 2020;13:e008390.
100. Yorgun H, Canpolat U, Kocyigit D, Çöteli C, Evranos B, Aytemir K.
Left atrial appendage isolation in addition to pulmonary vein isolation
in persistent atrial fibrillation: one-year clinical outcome after
cryoballoon-based ablation. Europace 2017;19:758-768.
101. Romero J, Natale A, Cerna L et al. Imaging Integration to Localize
and Protect the Left Coronary Artery in Patients Undergoing LAAEI. JACC:
Clinical Electrophysiology 2020;6:157-167.
102. Romero J, Tarantino N, Cerrud-Rodriguez R, Alviz I, Grupposso V, Di
Biase L. Segmental left atrial appendage electrical isolation to avoid
left phrenic nerve damage. HeartRhythm Case Rep 2019;5:269-273.
103. Rillig A, Tilz RR, Lin T et al. Unexpectedly High Incidence of
Stroke and Left Atrial Appendage Thrombus Formation After Electrical
Isolation of the Left Atrial Appendage for the Treatment of Atrial
Tachyarrhythmias. Circ Arrhythm Electrophysiol 2016;9:e003461.
104. Di Biase L, Mohanty S, Trivedi C et al. Stroke Risk in Patients
With Atrial Fibrillation Undergoing Electrical Isolation of the
Left Atrial Appendage. J Am Coll Cardiol 2019;74:1019-1028.
105. Holmes DR, Reddy VY, Turi ZG et al. Percutaneous closure of the
left atrial appendage versus warfarin therapy for prevention of stroke
in patients with atrial fibrillation: a randomised non-inferiority
trial. Lancet 2009;374:534-42.
106. Chatterjee S, Herrmann HC, Wilensky RL et al. Safety and Procedural
Success of Left Atrial Appendage Exclusion With the Lariat Device: A
Systematic Review of Published Reports and Analytic Review of the FDA
MAUDE Database. JAMA Internal Medicine 2015;175:1104-1109.
107. Bartus K, Han FT, Bednarek J et al. Percutaneous Left Atrial
Appendage Suture Ligation Using the LARIAT Device in Patients With
Atrial Fibrillation. Initial Clinical Experience 2013;62:108-118.
108. Lakkireddy D, Afzal MR, Lee RJ et al. Short and long-term outcomes
of percutaneous left atrial appendage suture ligation: Results from a US
multicenter evaluation. Heart Rhythm 2016;13:1030-1036.
109. David J Wilber M, Dhanunjaya Lakkireddy M, FHRS. Outcomes of
Adjunctive LAA Utilizing LARIAT Compared to Pulmonary Vein Atrial
Isolation Alone. in press.
110. Dearstine M, Taylor W, Kerut EK. Persistent left superior vena
cava: chest x-ray and echocardiographic findings. Echocardiography
2000;17:453-5.
111. Kim YG, Han S, Choi J-I et al. Impact of persistent left superior
vena cava on radiofrequency catheter ablation in patients with atrial
fibrillation. EP Europace 2019;21:1824-1832.
112. Santoro F, Rillig A, Sohns C et al. Second-Generation Cryoballoon
Atrial Fibrillation Ablation in Patients With Persistent Left Superior
Caval Vein. JACC Clin Electrophysiol 2019;5:590-598.
113. Fujino T, Yuzawa H, Kinoshita T, Shinohara M, Okishige K, Ikeda T.
A case of successful cryoballoon ablation of paroxysmal atrial
fibrillation originating from a persistent left superior vena cava. J
Cardiol Cases 2019;20:77-80.
114. Briceño DF, Valderrábano M. Recurrent perimitral flutter due to
vein of Marshall epicardial connections bypassing the mitral isthmus:
response to ethanol infusion. Circulation Arrhythmia and
electrophysiology 2014;7:988-989.
115. Kurotobi T, Ito H, Inoue K et al. Marshall vein as arrhythmogenic
source in patients with atrial fibrillation: correlation between its
anatomy and electrophysiological findings. J Cardiovasc Electrophysiol
2006;17:1062-7.
116. Rodríguez-Mañero M, Schurmann P, Valderrábano M. Ligament and vein
of Marshall: A therapeutic opportunity in atrial fibrillation. Heart
rhythm 2016;13:593-601.
117. Chugh A, Gurm HS, Krishnasamy K et al. Spectrum of atrial
arrhythmias using the ligament of Marshall in patients with atrial
fibrillation. Heart Rhythm 2018;15:17-24.
118. Valderrábano M, Peterson LE, Swarup V et al. Effect of Catheter
Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation
Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical
Trial. JAMA 2020;324:1620-1628.
119. Lador A, Valderrabano M. B-PO05-066 VEIN OF MARSHALL ALCOHOL IN
REPEAT ABLATION OF PERSISTENT ATRIAL FIBRILLATION (MARS-AF). Heart
Rhythm 2021;18:S398.
120. Steinberg JS, Shabanov V, Ponomarev D et al. Effect of Renal
Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial
Fibrillation Recurrence Among Patients With Paroxysmal Atrial
Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical
Trial. Jama 2020;323:248-255.
121. Ukena C, Becker N, Pavlicek V et al. Catheter-based renal
denervation as adjunct to pulmonary vein isolation for treatment of
atrial fibrillation: a systematic review and meta-analysis. J Hypertens
2020;38:783-790.
122. Kewcharoen J, Vutthikraivit W, Rattanawong P et al. Renal
sympathetic denervation in addition to pulmonary vein isolation reduces
the recurrence rate of atrial fibrillation: an updated meta-analysis of
randomized control trials. Journal of Interventional Cardiac
Electrophysiology 2020.
123. Kitamura T, Takigawa M, Derval N et al. Atrial tachycardia circuits
include low voltage area from index atrial fibrillation ablation
relationship between RF ablation lesion and AT. Journal of
Cardiovascular Electrophysiology 2020;31:1640-1648.
124. Clarnette JA, Brooks AG, Mahajan R et al. Outcomes of persistent
and long-standing persistent atrial fibrillation ablation: a systematic
review and meta-analysis. Europace : European pacing, arrhythmias, and
cardiac electrophysiology : journal of the working groups on cardiac
pacing, arrhythmias, and cardiac cellular electrophysiology of the
European Society of Cardiology 2018;20:f366-f376.
125. Fiala M, Chovančík J, Nevřalová R et al. Pulmonary vein isolation
using segmental versus electroanatomical circumferential ablation for
paroxysmal atrial fibrillation. Journal of Interventional Cardiac
Electrophysiology 2008;22:13-21.
126. Liu X, Long D, Dong J et al. Is Circumferential Pulmonary Vein
Isolation Preferable to Stepwise Segmental Pulmonary Vein Isolation for
Patients With Paroxysmal Atrial Fibrillation?
A Randomized Study. Circulation Journal 2006;70:1392-1397.
127. Oral H, Scharf C, Chugh A et al. Catheter ablation for paroxysmal
atrial fibrillation: segmental pulmonary vein ostial ablation versus
left atrial ablation. Circulation 2003;108:2355-60.
128. Arentz T, Weber R, Bürkle G et al. Small or large isolation areas
around the pulmonary veins for the treatment of atrial fibrillation?
Results from a prospective randomized study. Circulation
2007;115:3057-63.
129. Jin Hwang H, Myung Lee J, Joung B et al. Atrial electroanatomical
remodeling as a determinant of different outcomes between two current
ablation strategies: circumferential pulmonary vein isolation vs
pulmonary vein isolation. Clin Cardiol 2010;33:E69-74.
130. Mansour M, Ruskin J, Keane D. Efficacy and safety of segmental
ostial versus circumferential extra-ostial pulmonary vein isolation for
atrial fibrillation. J Cardiovasc Electrophysiol 2004;15:532-7.
131. CHEN M, YANG B, CHEN H et al. Randomized Comparison Between
Pulmonary Vein Antral Isolation versus Complex Fractionated Electrogram
Ablation for Paroxysmal Atrial Fibrillation. Journal of Cardiovascular
Electrophysiology 2011;22:973-981.
132. DEISENHOFER I, ESTNER H, REENTS T et al. Does Electrogram Guided
Substrate Ablation Add to the Success of Pulmonary Vein Isolation in
Patients with Paroxysmal Atrial Fibrillation? A Prospective, Randomized
Study. Journal of Cardiovascular Electrophysiology 2009;20:514-521.
133. Di Biase L, Elayi CS, Fahmy TS et al. Atrial fibrillation ablation
strategies for paroxysmal patients: randomized comparison between
different techniques. Circ Arrhythm Electrophysiol 2009;2:113-9.
134. Nührich JM, Steven D, Berner I et al. Impact of biatrial
defragmentation in patients with paroxysmal atrial fibrillation: results
from a randomized prospective study. Heart Rhythm 2014;11:1536-42.
135. Verma A, Patel D, Famy T et al. Efficacy of adjuvant anterior left
atrial ablation during intracardiac echocardiography-guided pulmonary
vein antrum isolation for atrial fibrillation. J Cardiovasc
Electrophysiol 2007;18:151-6.
136. Fadahunsi O, Talabi T, Olowoyeye A, Iluyomade A, Shogbesan O,
Donato A. Ablation of Complex Fractionated Atrial Electrograms for
Atrial Fibrillation Rhythm Control: A Systematic Review and
Meta-analysis. Can J Cardiol 2016;32:791-802.
137. Verma A, Novak P, Macle L et al. A prospective, multicenter
evaluation of ablating complex fractionated electrograms (CFEs) during
atrial fibrillation (AF) identified by an automated mapping algorithm:
acute effects on AF and efficacy as an adjuvant strategy. Heart Rhythm
2008;5:198-205.
138. Vogler J, Willems S, Sultan A et al. Pulmonary Vein Isolation
Versus Defragmentation: The CHASE-AF Clinical Trial. J Am Coll Cardiol
2015;66:2743-2752.
139. Oral H, Chugh A, Yoshida K et al. A Randomized Assessment of the
Incremental Role of Ablation of Complex Fractionated Atrial Electrograms
After Antral Pulmonary Vein Isolation for Long-Lasting Persistent Atrial
Fibrillation. Journal of the American College of Cardiology
2009;53:782-789.
140. Wong KC, Paisey JR, Sopher M et al. No Benefit of Complex
Fractionated Atrial Electrogram Ablation in Addition to Circumferential
Pulmonary Vein Ablation and Linear Ablation: Benefit of Complex Ablation
Study. Circulation Arrhythmia and electrophysiology 2015;8:1316-24.
141. Elayi CS, Verma A, Di Biase L et al. Ablation for longstanding
permanent atrial fibrillation: Results from a randomized study comparing
three different strategies. Heart Rhythm 2008;5:1658-1664.
142. LIN Y-J, TAI C-T, CHANG S-L et al. Efficacy of Additional Ablation
of Complex Fractionated Atrial Electrograms for Catheter Ablation of
Nonparoxysmal Atrial Fibrillation. Journal of Cardiovascular
Electrophysiology 2009;20:607-615.
143. Dixit S, Marchlinski FE, Lin D et al. Randomized ablation
strategies for the treatment of persistent atrial fibrillation: RASTA
study. Circ Arrhythm Electrophysiol 2012;5:287-94.
144. Sawhney N, Anousheh R, Chen W, Feld GK. Circumferential pulmonary
vein ablation with additional linear ablation results in an increased
incidence of left atrial flutter compared with segmental pulmonary vein
isolation as an initial approach to ablation of paroxysmal atrial
fibrillation. Circulation Arrhythmia and electrophysiology 2010;3:243-8.
145. Wynn GJ, Panikker S, Morgan M et al. Biatrial linear ablation in
sustained nonpermanent AF: Results of the substrate modification with
ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation
(SMAN-PAF) trial. Heart Rhythm 2016;13:399-406.
146. Gaita F, Caponi D, Scaglione M et al. Long-term clinical results of
2 different ablation strategies in patients with paroxysmal and
persistent atrial fibrillation. Circ Arrhythm Electrophysiol
2008;1:269-75.
147. FASSINI G, RIVA S, CHIODELLI R et al. Left Mitral Isthmus Ablation
Associated with PV Isolation: Long-Term Results of a Prospective
Randomized Study. Journal of Cardiovascular Electrophysiology
2005;16:1150-1156.
148. Willems S, Klemm H, Rostock T et al. Substrate modification
combined with pulmonary vein isolation improves outcome of catheter
ablation in patients with persistent atrial fibrillation: a prospective
randomized comparison. Eur Heart J 2006;27:2871-8.
149. Wazni O, Marrouche NF, Martin DO et al. Randomized study comparing
combined pulmonary vein-left atrial junction disconnection and
cavotricuspid isthmus ablation versus pulmonary vein-left atrial
junction disconnection alone in patients presenting with typical atrial
flutter and atrial fibrillation. Circulation 2003;108:2479-83.
150. Lee WC, Fang HY, Chen HC et al. Additional cavotricuspid isthmus
block ablation may not improve the outcome of atrial fibrillation
ablation. Pacing Clin Electrophysiol 2019;42:1421-1428.
151. WANG Y-L, LIU X, TAN H-W et al. Evaluation of Linear Lesions in the
Left and Right Atrium in Ablation of Long-standing Atrial Fibrillation.
Pacing and Clinical Electrophysiology 2013;36:1202-1210.
152. Mohanty S, Gianni C, Trivedi C et al. Impact of rotor ablation in
non-paroxysmal AF patients: Findings from the per-protocol population of
the OASIS trial at long-term follow-up. Am Heart J 2018;205:145-148.
153. Brachmann J, Hummel JD, Wilber DJ et al. Prospective randomized
comparison of rotor ablation vs conventional ablation for treatment of
persistent atrial fibrillation—The REAFFIRM trial. Heart Rhythm
2019;16:963-965.
154. Peigh G, Wasserlauf J, Kaplan RM et al. Abstract 15877: Focal
Impulse Rotor Modulation Guided Ablation versus Isolated Repeat
Pulmonary Vein Isolation of Non-Paroxysmal Atrial Fibrillation After
Failed Pulmonary Vein Isolation: A Case Control Study. Circulation
2019;140:A15877-A15877.
155. Kirzner JM, Raelson CA, Liu CF et al. Effects of focal impulse and
rotor modulation-guided ablation on atrial arrhythmia termination and
inducibility: Impact on outcomes after treatment of persistent atrial
fibrillation. J Cardiovasc Electrophysiol 2019;30:2773-2781.
156. Rolf S, Kircher S, Arya A et al. Tailored Atrial Substrate
Modification Based on Low-Voltage Areas in Catheter Ablation of Atrial
Fibrillation. Circulation: Arrhythmia and Electrophysiology
2014;7:825-833.
157. Jadidi AS, Lehrmann H, Keyl C et al. Ablation of Persistent Atrial
Fibrillation Targeting Low-Voltage Areas With Selective Activation
Characteristics. Circulation: Arrhythmia and Electrophysiology
2016;9:e002962.
158. Mikhaylov E, Kanidieva A, Sviridova N et al. Outcome of anatomic
ganglionated plexi ablation to treat paroxysmal atrial fibrillation: a
3-year follow-up study. Europace 2011;13:362-70.
159. Kim T-H, Park J, Park J-K et al. Linear ablation in addition to
circumferential pulmonary vein isolation (Dallas lesion set) does not
improve clinical outcome in patients with paroxysmal atrial
fibrillation: a prospective randomized study. EP Europace
2014;17:388-395.
160. Lim TW, Koay CH, See VA et al. Single-Ring Posterior Left Atrial
(Box) Isolation Results in a Different Mode of Recurrence Compared With
Wide Antral Pulmonary Vein Isolation on Long-Term Follow-Up.
Circulation: Arrhythmia and Electrophysiology 2012;5:968-977.
161. Sutter JS, Lokhnygina Y, Daubert JP et al. Safety and efficacy
outcomes of left atrial posterior wall isolation compared to pulmonary
vein isolation and pulmonary vein isolation with linear ablation for the
treatment of persistent atrial fibrillation. Am Heart J 2020;220:89-96.
162. Aryana A, Baker JH, Espinosa Ginic MA et al. Posterior wall
isolation using the cryoballoon in conjunction with pulmonary vein
ablation is superior to pulmonary vein isolation alone in patients with
persistent atrial fibrillation: A multicenter experience. Heart Rhythm
2018;15:1121-1129.
163. Wang XH, Liu X, Sun YM, Shi HF, Zhou L, Gu JN. Pulmonary vein
isolation combined with superior vena cava isolation for atrial
fibrillation ablation: a prospective randomized study. Europace
2008;10:600-5.
164. Da Costa A, Levallois M, Romeyer-Bouchard C, Bisch L, Gate-Martinet
A, Isaaz K. Remote-controlled magnetic pulmonary vein isolation combined
with superior vena cava isolation for paroxysmal atrial fibrillation: a
prospective randomized study. Arch Cardiovasc Dis 2015;108:163-71.
165. Heeger CH, Rillig A, Geisler D et al. Left Atrial Appendage
Isolation in Patients Not Responding to Pulmonary Vein Isolation.
Circulation 2019;139:712-715.
166. Panikker S, Jarman JW, Virmani R et al. Left Atrial Appendage
Electrical Isolation and Concomitant Device Occlusion to Treat
Persistent Atrial Fibrillation: A First-in-Human Safety, Feasibility,
and Efficacy Study. Circulation Arrhythmia and electrophysiology 2016;9.